Who are Adicet Bio, Inc.'s main suppliers?

Adicet Bio, Inc. (ACET) key suppliers include: COHORT-PHARMACEUTICALS-INC, CytoMed Therapeutics Limited. View the full supplier network at chainsifter.com/chain/ACET.

Who are Adicet Bio, Inc.'s major customers?

Adicet Bio, Inc. (ACET) key customers include: CytoMed Therapeutics Limited. View the full customer network at chainsifter.com/chain/ACET.

What sector is Adicet Bio, Inc. in?

Adicet Bio, Inc. (ACET) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

ACET Supply Chain: Adicet Bio, Inc. Suppliers & Customers

2Suppliers

1Customers

3Debt Items

20Related Chains

Adicet Bio, Inc. Suppliers

Ticker	Name	Confidence	Evidence
COHORT-PHARMACEUTICALS-INC	COHORT-PHARMACEUTICALS-INC	85%	The Company may pay fees for development and regulatory milestones that together total in the single digit millions of dollars and sales milestones in the low-to-mid double digit millions of dollars.
GDTC	CytoMed Therapeutics Limited	72%	Reciprocal relationship from GDTC graph: l expansion. ATPL retained the right to use all products and/or services the Company creates which contain or incorporate the modified human K562 cells. Any n…

Adicet Bio, Inc. Customers

Ticker	Name	Confidence	Evidence
GDTC	CytoMed Therapeutics Limited	72%	Reciprocal relationship from GDTC graph: Reciprocal relationship from ACET graph: Reciprocal relationship from GDTC graph: l expansion. ATPL retained the right to use all products and/or services the…

Adicet Bio, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
ACET-DEBT-7455	Warrants outstanding: 38.3984	90%	xbrl warrant detail from xbrl 2025-12-31.
ACET-DEBT	Debt stack $13.9M	90%	Market cache reports total debt of $13.9M.
ACET-DEBT-7456	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2020-12-31.

Adicet Bio, Inc. Acquisitions

Acquired Entity	Name	Confidence	Evidence
ACET-ACQ-0001720580-26-000023	Adicet Bio, Inc. issued a pre-funded warrant to acquire 250,000 shares of common stock.	85%	Adicet Bio, Inc. issued a pre-funded warrant to acquire 250,000 shares of common stock.

Adicet Bio, Inc. Ownership

Holder	Name	Confidence	Evidence
ACET-OWNER-BARCLAYS-PLC	BARCLAYS PLC	90%	13F overlay lists BARCLAYS PLC as top holder; 5 tracked holders.

Adicet Bio, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
IBIO	iBio, Inc.	100.00	2
TKPHF	Takeda Pharmaceutical Company Limited	100.00	2
IMTX	Immatics N.V.	100.00	2
BDRX	Biodexa Pharmaceuticals Plc	100.00	2
IPSC	Century Therapeutics, Inc.	100.00	2
KLRS	Kalaris Therapeutics, Inc.	100.00	2
CRBU	Caribou Biosciences, Inc.	100.00	2
GILD	Gilead Sciences, Inc.	100.00	2
ALLO	Allogene Therapeutics, Inc.	100.00	2
FATE	Fate Therapeutics, Inc.	100.00	2
GRAL	GRAIL, Inc.	100.00	2
AUTL	Autolus Therapeutics plc	100.00	2
ALNY	Alnylam Pharmaceuticals, Inc.	100.00	2
EDSA	Edesa Biotech, Inc.	100.00	2
CHRS	Coherus Oncology, Inc.	100.00	2
ARTV	Artiva Biotherapeutics, Inc.	100.00	1	['spend']
CELU	Celularity Inc.	100.00	2
REGN	Regeneron Pharmaceuticals, Inc.	100.00	1	['receiving']
TBPH	Theravance Biopharma, Inc.	100.00	2
AZTA	Azenta, Inc.	100.00	2

Adicet Bio, Inc. Supply Chain